N-Hydroxy-nor-L-arginine (nor-NOHA) is under investigation in clinical trial NCT02009527 (Arginase Inhibition in Ischemia-reperfusion Injury).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.